Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma

Yu Qian; Jing-Wen Wang; Yu Fang; Xiao-Dong Yuan; Yu-Chen Fan; Shuai Gao; Kai Wang

doi:10.12659/MSM.927444

15 December 2020 : Clinical Research

Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma

Yu Qian^1ABCDEF, Jing-Wen Wang^1BC, Yu Fang^1BCD, Xiao-Dong Yuan^1B, Yu-Chen Fan^12ADF, Shuai Gao^12CDFG, Kai Wang^12ADEG*

DOI: 10.12659/MSM.927444

Med Sci Monit 2020; 26:e927444

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 Classification of 118 HCC and 47 LC patients according to AFP concentrations and CCND2 methylation status in plasma. AFP – alpha-fetoprotein; HCC – hepatocellular carcinoma; LC – liver cirrhosis.

Back to the Article

Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma

Your Privacy